G. Calderillo

Retrospective Analysis of Chilean and Mexican GI Stromal Tumor Registries: A Tale of Two Latin American Realities

G. Calderillo, Matías Muñoz-Medel, Edelmira Carbajal, 2020, JCO global oncology.

Long-term results of paclitaxel in FIGO stage III ovarian carcinoma

L. Oñate-Ocaña, A. Mohar, A. Dueñas-González, 2003, Anti-cancer drugs.

Methylenetetrahydrofolate reductase polymorphism (677 C>T) predicts long time to progression in metastatic colon cancer treated with 5-fluorouracil and folinic acid.

M. Santibáñez, L. Herrera, G. Calderillo, 2010, Archives of medical research.

Cancer pain management: recommendations from a Latin-American experts panel.

O. Barajas, G. Calderillo, A. del Giglio, 2017, Future oncology.

Cisplatin, radiation, and amifostine in carcinoma of the uterine cervix.

A. Mohar, G. Calderillo, J. G. De la Garza, 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

A phase II study of gemcitabine plus cisplatin in previously untreated advanced ovarian cancer.

G. Calderillo, J. G. De la Garza, A. Serrano, 2006, Anticancer research.

Phase II Study of Neo‐adjuvant Gemcitabine Plus Epirubicin in Primarily Unresectable Locally Advanced Breast Cancer

G. Calderillo, J. G. De la Garza, D. Gallardo, 2008, The breast journal.

Phase II study of gemcitabine plus cisplatin in metastatic breast cancer

L. Oñate-Ocaña, G. Calderillo, D. Gallardo, 2006, Anti-cancer drugs.

Adaptation of the questionnaire EORTC QLQ-STO22 to measure quality of life from Mexican patients with gastric carcinoma

L. Oñate, G. Calderillo, V. Aiello, 2007, BMC Cancer.